Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Latest News

News : Latest News

 Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
09:47aWELL HEALTH TECHNOLOGIES : Completes its Seventh EMR Acquisition with the Closing of Indivica Acquisition
AQ
09:47aHow OEMs Can Leverage Supply Chain Demand Planning Solutions to Mitigate the Effects of COVID-19 | Quantzig's Success Story Offers Intricate Insights
BU
09:46aOil falls as U.S.-China tension escalates
RE
09:46aPOLYMET MINING : 2019 December ESTMA
PU
09:46aOLAINFARM : Interim report (Q1 and Q3) Operational and financial stability are priorities of Olainfarm Group
PU
09:46aHAEMONETICS : Jefferies Virtual Healthcare Conference Presentation
PU
09:46aIHS MARKIT : Poland's PMI rises but remains deep in coronavirus trough
AQ
09:46aProfessional Haircare Products Market 2020-2024 | Expansion of the Spa Market to Boost Growth | Technavio
BU
09:46aCARNIVAL CRUISE LINE Nationally Ranked Labaton Sucharow Announces Complaint on Behalf of Stock, Options, and Derivative Purchasers and Strongly Encourages Investors to Contact The Firm
BU
09:46aFiat Chrysler Names Paolo Carmassi as Chief Executive of Comau
DJ
09:45aLagos court rulings complicate Nigeria's plan for oilfield licensing round
RE
09:45aUNITED STATES : Final Manufacturing PMI as estimates at 39.8
09:45aRich world's jobs crisis jolts money flows to millions
RE
09:45aCVS HEALTH : to Present at Goldman Sachs 41st Annual Global Healthcare Conference
PR
09:45aTapestry Telehealth is now TapestryHealth
PR
Discover
09:44aSONA NANOTECH : IIROC Trading Halt - SONA
AQ
09:43aWall St. dips amid U.S. protests, China tensions
RE
09:43a18 Squared and CapZone Announce Opportunity Zone Investment
BU
09:43aSTRATEGY ANALYTICS : Ultrawideband Chips on the Threshold of Success
BU
09:42aFacebook, Snapchat join chorus of companies condemning George Floyd death, racism
RE
09:42aFIRST UNITED CORP/MD/ : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09:42aELLIE MAE : Virtual Experience 2020 Sees Successful Conclusion
AQ
09:41aDAIICHI SANKYO : AstraZeneca - Enhertu significantly improved tumour response rate and overall survival in HER2-positive metastatic gastric cancer in Phase II DESTINY-Gastric01 trial
AQ
09:41aBRIDGEBIO PHARMA : QED Therapeutics Presents Data on Infigratinib In Cholangiocarcinoma and Urothelial Carcinoma
AQ
09:41aDAIICHI SANKYO : AstraZeneca and Daiichi Sankyo Company, Limited - Enhertu achieved a tumour response rate of 45.3% in patients with HER2-positive metastatic colorectal cancer
AQ
09:41aNOVARTIS : announces long-term, relapse-free survival benefit for high-risk, stage III melanoma patients treated with Tafinlar + Mekinist following surgery
AQ
09:41aALLOGENE THERAPEUTICS : With collaborator servier, reports positive results from its phase 1 alpha study of allo-501 in relapsed/refractory non-hodgkin lymphoma
AQ
09:41aAUTOLUS THERAPEUTICS : presents additional data on AUTO3 in DLBCL during the ASCO20 Virtual Scientific Program
AQ
09:41aHARPOON THERAPEUTICS : Presents interim phase 1 data from an ongoing dose escalation trial for the psma-targeting tritac hpn424 at the asco20 virtual scientific program
AQ
09:41aGENOCEA BIOSCIENCES : Presents updated long-term safety, immunogenicity and durability data from gen-009 neoantigen vaccine phase 1/2a trial part a at virtual asco 2020
AQ
09:41aNGM BIOPHARMACEUTICALS : Bio to Present at Two Upcoming Investor Conferences
AQ
09:41aOncolytics Biotech Presents Clinical Proof-of-Concept Data in Multiple Myeloma at the ASCO Virtual Annual Meeting
AQ
09:41aCHUGAI PHARMACEUTICAL : Updated Data of Overall Survival and Safety from the ALEX Study for Chugai's Alecensa Presented at the 2020 American Society of Clinical Oncology
AQ
09:41aREGENERON PHARMACEUTICALS : - libtayo longer-term results in advanced cutaneous squamous cell carcinoma presented at asco 2020 show durable responses that deepen over time
AQ
09:41aDAIICHI SANKYO : AstraZeneca - Enhertu demonstrated meaningful clinical activity in patients with HER2-mutant non-small cell lung cancer in interim analysis of Phase II DESTINY-Lung01 trial
AQ
09:41aSUN PHARMACEUTICAL INDUSTRIES : Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients
AQ
09:41aPFIZER : Provides update on phase 3 pallas trial of ibrance plus endocrine therapy in hr+, her2- early breast cancer
AQ
09:41aNOVO NORDISK A/S : Basilea announces appointment of new Head of Global Quality Management
AQ
09:41aChugai Files Patent Infringement Lawsuit concerning Edirol Capsules against Sawai and Nichi-Iko
AQ
09:41aREGENERON PHARMACEUTICALS : Completes secondary offering of common stock held by sanofi
AQ
09:41aCHUGAI PHARMACEUTICAL : Obtains Approval for Expanded Use of FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic of Novartis' MET inhibitor, Capmatinib
AQ
09:41aTrillium Therapeutics Provides Update on the Phase I Dose Escalation Study of Its CD47 Blocker TTI-622 at the ASCO20 Virtual Scientific Program
AQ
09:41aMYOVANT SCIENCES : Announces Additional Positive Efficacy and Cardiovascular Safety Data from Phase 3 HERO Study of Once-Daily, Oral Relugolix in Advanced Prostate Cancer
AQ
09:41aKALYTERA THERAPEUTICS : Announces Data Demonstrating that R-107 Preserves Organ Function in a Murine Study Mimicking COVID-19 Lung Disease
AQ
09:41aSUMITOMO DAINIPPON PHARMA : Announces Merger of US consolidated subsidiaries
AQ
09:41aChugai and FRONTEO Enter into a License Agreement for AI-based Drug Discovery Support System
AQ
09:41aLIGAND PHARMACEUTICALS INCORPORATED : Announces icagen's expansion of collaboration with roche to develop and commercialize therapies for neurological diseases
AQ
09:41aGLYCOMIMETICS : to Present at Upcoming Jefferies Virtual Healthcare Conference
AQ
09:41aAMNEAL PHARMACEUTICALS : LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg
AQ
09:41aCARDIOL THERAPEUTICS TO WEBCAST VIRTUAL ANNUAL GENERAL MEETING ON JUNE 1ST AT 4 : 30 p.m. EDT
AQ
09:41aAffimed Highlights Study Design of its AFM13 REDIRECT Trial at the ASCO 2020 Virtual Meeting
AQ
09:41aXSPRAY PHARMA PUBL : initiates pivotal registration studies with HyNap-Dasa for the market approval application in the United States
AQ
09:41aABBVIE : FDA Approves the First Oral Medication for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women
AQ
09:41aINITIATOR PHARMA A/S : - Publication of memorandum
AQ
09:41aASTRAZENECA : Imfinzi plus tremelimumab demonstrated promising clinical activity and tolerability in patients with advanced liver cancer
AQ
09:41aSYROS PHARMACEUTICALS : Presents New Preclinical Data on SY-5609 at 2020 ASCO Virtual Scientific Program
AQ
09:41aINTELLIPHARMACEUTICS INTERNATIONAL : Announces First Quarter 2020 Results
AQ
09:41aMARKER THERAPEUTICS : Reports interim results of its multitaa-specific t cell therapy in patients with pancreatic adenocarcinoma
AQ
09:41aASTRAZENECA : Imfinzi showed a sustained overall survival benefit in 1st-line extensive-stage small cell lung cancer in the Phase III CASPIAN trial
AQ
09:41aMODERNA : Announces First Participants in Each Age Cohort Dosed in Phase 2 Study of mRNA Vaccine against Novel Coronavirus
AQ
1  2  3  4  5  6  7  8  9  10Next